Neurology Minute

Dr. Jonathan Graff-Radford, guest editor of the February 2019 Continuum Dementia issue , discusses posterior cortical atrophy. To learn more, read the article "Posterior Cortical Atrophy" by Dr. Jonathan M. Schott and Dr. Sebastian J. Crutch in that issue.

Dr. Tamara Pringsheim discusses guideline recommendations on assessment and management of tics in people with Tourette's Syndrome and chronic tic disorders.

New York Times staff writer Pam Belluck discusses the WHO and regulation on human gene editing. Read her March 19, 2019, article here: https://www.nytimes.com/2019/03/19/health/who-panel-demands-a-registry-for-human-gene-editing.html. 

Dr. Jason Crowell discusses skyrocketing costs of a drug used for treatment with Lambert-Eaton myasthenic syndrome. 

Dr. Rae Bacharach discusses trends in medical clerkships in neurology.

Dr. Jonathan Graff-Radford, guest editor of the February 2019 Continuum Dementia issue , discusses early-onset Alzheimer Disease. To learn more, read the article "Early-onset Alzheimer Disease and Its Variants" by Dr. Mario F. Mendez in that issue.

Dr. Jenny Linnoila discusses the main takeaways from her podcast interview and paper on a mouse model of anti-NMDA receptor post-herpes simplex encephalitis. 

Pam Belluck of the New York Times discusses He Jiankui, gene editing and CRISPR. Read one of the articles on the issue here:  https://www.nytimes.com/2019/04/14/health/gene-editing-babies.html

Dr. Rae Bacharach discusses two new, disease-modifying therapies for use in multiple sclerosis.

Dr. Gregory Day discusses the recognition of transient epileptic amnesia. To learn more, read Dr. Day's article, "Reversible Dementias," in the February 2019 Dementia issue of Continuum.

Dr. Brigid Waldron-Perrine talks about the  Montreal Cognitive Assessment as a screening tool.

Dr. Mathias Jucker discusses the use of neurofilament light as a potential biomarker for Alzheimer's Disease.

Dr. Jonathan Graff-Radford, guest editor of the February 2019 Dementia issue of Continuum , discusses behavioral-variant frontotemporal dementia. To learn more, read the article "Behavioral Variant Frontotemporal Dementia" by Dr. William W. Seeley in that issue.

Dr. Mathias Buron discusses the takeaways from his paper the c omparative effectiveness of teriflunomide and dimethyl fumarate.

Dr. Joanna Hellmuth discusses the findings of her paper on the rise of pseudomedicine for dementia and brain health.  

Dr. Roy Strowd discusses a recent Clinical Reasoning case about a 65-year-old female with subacute hemiballism. 

Dr. Jonathan Graff-Radford, guest editor of the February 2019 Dementia issue of Continuum , discusses hippocampal sclerosis of aging. To learn more, read the article "Hippocampal Sclerosis, Argyrophilic Grain Disease, and Primary Age-related Tauopathy" by Drs. Gregory A. Jicha and Peter T. Nelson in that issue.

Dr. Caterina Lapucci talks about her paper addressing how much periventricular lesions assist in distinguishing migraine with aura from CIS. 

Sarah Karlin-Smith and Sarah Owermohle from Politico talk about drug pricing and legislation to affect drug pricing.

Dr. Roy Strowd showcases a Clinical Reasoning case on a pregnant woman presenting with chin numbness.

Dr. Gregory Day offers a practical approach to recognizing patients with reversible dementia. To learn more, read Dr. Day's article, "Reversible Dementias," in the February 2019 Dementia issue of Continuum .

Dr. Stephan Schuele discusses the main takeaways from his paper on automated seizure detection accuracy for ambulatory EEG recordings. 

Dr. Kevin Barrett discusses the SHINE stroke trial, which was designed to determine the optimal treatment of hyperglycemia in acute stroke.

Dr. Joe Sirven previews the upcoming 2019 AAN Annual Meeting in Philadelphia.

Dr. John Millichap discusses a clinical pediatric R&F case of a 15-year-old boy with bilateral wrist pain in the setting of weight loss.